• DOI:10.2147/DDDT.S126861
Corpus ID: 9319023

Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects

@article{Shin2017PharmacokineticsAT,
  title={Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects},
  author={D. Shin and S. Lee and S. Yi and S. Yoon and Joo-Youn Cho and Mi Young Bahng and I. Jang and Kyung-Sang Yu},
  journal={Drug Design, Development and Therapy},
  year={2017},
  volume={11},
  pages={713 - 723}
}

D. Shin, S. Lee, +5 authors Kyung-Sang Yu

Published 2017

Medicine

Drug Design, Development and Therapy

Objective DA-8031 is a selective serotonin reuptake inhibitor under development for the treatment of premature ejaculation. This is the first-in-human study aimed at evaluating the pharmacokinetics and tolerability of DA-8031 and its metabolites (M1, M2, M4, and M5) in the plasma and urine after administration of a single oral dose in healthy male subjects. Methods A dose block-randomized, double-blind, placebo-controlled, single ascending dose study was conducted. Subjects received either… CONTINUE READING

View PDF

Save to Library

Create Alert

Cite

Launch Research Feed